In our study , @ different bone marrow-derived stem cell approaches in AMI did not result in improvement of LVEF or volumes compared with standard AMI care ( Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction -LSB- TECAM -RSB- ; NCT@ ) .